These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31114959)

  • 1. Acetazolamide as a potent chloride-regaining diuretic: short- and long-term effects, and its pharmacologic role under the 'chloride theory' for heart failure pathophysiology.
    Kataoka H
    Heart Vessels; 2019 Dec; 34(12):1952-1960. PubMed ID: 31114959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Changes in Plasma Volume and Renal Function between Acetazolamide and Conventional Diuretics: Understanding the Mechanical Differences according to the "Chloride Theory".
    Kataoka H
    Cardiology; 2020; 145(4):215-223. PubMed ID: 31865322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical Determinants of Changes in Plasma Volume After Decongestion Therapy for Worsening Heart Failure.
    Kataoka H
    J Card Fail; 2019 Mar; 25(3):213-217. PubMed ID: 30296584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure.
    Ter Maaten JM; Damman K; Hanberg JS; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Cotter G; Davison B; Cleland JG; Bloomfield DM; Hillege HL; van Veldhuisen DJ; Voors AA; Testani JM
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27507112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal for heart failure progression based on the 'chloride theory': worsening heart failure with increased vs. non-increased serum chloride concentration.
    Kataoka H
    ESC Heart Fail; 2017 Nov; 4(4):623-631. PubMed ID: 29154432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hypochloremia with acetazolamide in an advanced heart failure patient and importance of monitoring urinary electrolytes.
    Kataoka H
    J Cardiol Cases; 2018 Mar; 17(3):80-84. PubMed ID: 30279861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Chloride and the Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload: A Post Hoc Analysis From the ADVOR Trial.
    Van den Eynde J; Martens P; Dauw J; Nijst P; Meekers E; Ter Maaten JM; Damman K; Filippatos G; Lassus J; Mebazaa A; Ruschitzka F; Dupont M; Mullens W; Verbrugge FH
    Circ Heart Fail; 2024 Oct; 17(10):e011749. PubMed ID: 39171394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypochloremia and Diuretic Resistance in Heart Failure: Mechanistic Insights.
    Hanberg JS; Rao V; Ter Maaten JM; Laur O; Brisco MA; Perry Wilson F; Grodin JL; Assefa M; Samuel Broughton J; Planavsky NJ; Ahmad T; Bellumkonda L; Tang WH; Parikh CR; Testani JM
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27507113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.
    Verbrugge FH; Martens P; Ameloot K; Haemels V; Penders J; Dupont M; Tang WHW; Droogné W; Mullens W
    Eur J Heart Fail; 2019 Nov; 21(11):1415-1422. PubMed ID: 31074184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diuretic, natriuretic, and chloride-regaining effects of oral acetazolamide as an add-on therapy for acute heart failure with volume overload: a single-center, prospective, randomized study.
    Kosiorek A; Urban S; Detyna J; Biegus J; Hurkacz M; Zymliński R
    Pol Arch Intern Med; 2023 Dec; 133(12):. PubMed ID: 37415505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study.
    Imiela T; Budaj A
    Clin Drug Investig; 2017 Dec; 37(12):1175-1181. PubMed ID: 28965280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of acetazolamide in the treatment of patients with refractory congestive heart failure.
    Núñez J; Heredia R; Payá A; Sanchis I; Del Prado S; Miñana G; Santas E; de la Espriella R; Núñez E; Sanchis J; Bayés-Genís A
    Cardiovasc Ther; 2018 Dec; 36(6):e12465. PubMed ID: 30191652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial.
    Mullens W; Verbrugge FH; Nijst P; Martens P; Tartaglia K; Theunissen E; Bruckers L; Droogne W; Troisfontaines P; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M
    Eur J Heart Fail; 2018 Nov; 20(11):1591-1600. PubMed ID: 30238574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Prespecified Analysis From the ADVOR Trial.
    Martens P; Dauw J; Verbrugge FH; Nijst P; Meekers E; Augusto SN; Ter Maaten JM; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
    Circulation; 2023 Jan; 147(3):201-211. PubMed ID: 36335479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
    Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
    JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of short-term omission of daily medication on the pathophysiology of heart failure.
    Dovancescu S; Pellicori P; Mabote T; Torabi A; Clark AL; Cleland JGF
    Eur J Heart Fail; 2017 May; 19(5):643-649. PubMed ID: 28295907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.
    Mullens W; Dauw J; Martens P; Verbrugge FH; Nijst P; Meekers E; Tartaglia K; Chenot F; Moubayed S; Dierckx R; Blouard P; Troisfontaines P; Derthoo D; Smolders W; Bruckers L; Droogne W; Ter Maaten JM; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M;
    N Engl J Med; 2022 Sep; 387(13):1185-1195. PubMed ID: 36027559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary composition during decongestive treatment in heart failure with reduced ejection fraction.
    Verbrugge FH; Nijst P; Dupont M; Penders J; Tang WH; Mullens W
    Circ Heart Fail; 2014 Sep; 7(5):766-72. PubMed ID: 25037309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of Serum Chloride Homeostasis in Acute Heart Failure (from ROSE-AHF).
    Grodin JL; Sun JL; Anstrom KJ; Chen HH; Starling RC; Testani JM; Tang WH
    Am J Cardiol; 2017 Jan; 119(1):78-83. PubMed ID: 27816115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.